Stock Comparison
Intuitive Surgical, Inc. vs Medtronic plc
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Intuitive Surgical, Inc.
ISRG · The Nasdaq Global Select Market
Weighted across the company's segments.
Full stock profile
Dive deeper into Intuitive Surgical, Inc.'s moat claims, evidence, and risks.
View ISRG analysisMedtronic plc
MDT · New York Stock Exchange
Weighted across the company's segments.
Full stock profile
Dive deeper into Medtronic plc's moat claims, evidence, and risks.
View MDT analysisComparison highlights
- Moat score gap: Intuitive Surgical, Inc. leads (84 / 100 vs 58 / 100 for Medtronic plc).
- Segment focus: Intuitive Surgical, Inc. has 3 segments (59.8% in Instruments and Accessories); Medtronic plc has 4 segments (42% in Cardiovascular Portfolio).
- Primary market structure: Monopoly vs Oligopoly. Pricing power: Strong vs Moderate.
- Moat breadth: Intuitive Surgical, Inc. has 3 moat types across 2 domains; Medtronic plc has 3 across 1.
Primary market context
Intuitive Surgical, Inc.
Instruments and Accessories
Proprietary robotic surgery instruments, accessories, and consumables used per procedure on the da Vinci (and Ion) installed base
Global
Hospitals and surgery centers purchasing consumables; surgeons and OR teams as end users
Consumables OEM within proprietary platform
59.8%
Medtronic plc
Cardiovascular Portfolio
Cardiovascular medical devices (cardiac rhythm management, electrophysiology/ablation, structural heart, coronary & peripheral vascular)
Global
Hospitals, cath labs, electrophysiologists, cardiologists, cardiac & vascular surgeons
Device OEM + procedure support + remote monitoring software/services
42%
Side-by-side metrics
Moat coverage
Shared moat types
Intuitive Surgical, Inc. strengths
Medtronic plc strengths
Segment mix
Intuitive Surgical, Inc. segments
Full profile >Systems
Quasi-Monopoly
Instruments and Accessories
Monopoly
Services
Monopoly
Medtronic plc segments
Full profile >Cardiovascular Portfolio
Oligopoly
Neuroscience Portfolio
Oligopoly
Medical Surgical Portfolio
Competitive
Former Diabetes / MiniMed (separated October 2026)
Oligopoly
Act on this comparison
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.